Unknown

Dataset Information

0

Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates.


ABSTRACT: The efficacy of ALVAC-based HIV and SIV vaccines in humans and macaques correlates with antibodies to envelope variable region 2 (V2). We show here that vaccine-induced antibodies to SIV variable region 1 (V1) inhibit anti-V2 antibody-mediated cytotoxicity and reverse their ability to block V2 peptide interaction with the α4β7 integrin. SIV vaccines engineered to delete V1 and favor an α helix, rather than a β sheet V2 conformation, induced V2-specific ADCC correlating with decreased risk of SIV acquisition. Removal of V1 from the HIV-1 clade A/E A244 envelope resulted in decreased binding to antibodies recognizing V2 in the β sheet conformation. Thus, deletion of V1 in HIV envelope immunogens may improve antibody responses to V2 virus vulnerability sites and increase the efficacy of HIV vaccine candidates.

SUBMITTER: Silva de Castro I 

PROVIDER: S-EPMC7847973 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3421697 | biostudies-literature
| S-EPMC3067966 | biostudies-literature
| S-EPMC6616373 | biostudies-literature
| S-EPMC4654981 | biostudies-literature
| S-EPMC5516621 | biostudies-literature
| S-EPMC2612307 | biostudies-literature
| S-EPMC3911571 | biostudies-literature
| S-EPMC2657473 | biostudies-literature
| S-EPMC3068023 | biostudies-literature
| S-EPMC3726596 | biostudies-literature